Exlites Holdings International, Inc. (OTCPINK: EXHI) announced that it has issued a Letter of Intent ("LOI") to purchase a medical device company that will provide an existing sales force in proven markets with next generation products. Under the LOI, Exlites will provide use its stock to complete the acquisition and purchase 100% of the target company's issued and outstanding common stock, which will make the target company a wholly-owned subsidiary of Exlites.

Exlites' CEO, Joseph Chung, stated that the acquisition should be completed within the next two weeks. The acquisition will increase the Company's product offerings and provide for new distribution channels and a seasoned sales force, Chung stated.

Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval.

About Exlites Holdings International Inc.

Exlites Holdings International Inc. was operated in Japan for a number of years before moving to the United States. The Company's products are sold online and through the company's affiliate and distribution programs. The Company is dedicated to offering medical equipment to hospitals, assisted living facilities and to private individuals who seek quality medical equipment at cost effective prices. The Company's website is at www.exlitesmedical.com.

Forward-Looking Statements

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

CONTACT:

Exlites Holdings International, Inc.

info@exlitesmedical.com

SOURCE: Exlites Holdings International, Inc.

© 2024 Canjex Publishing Ltd. All rights reserved.